These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24749839)

  • 61. Second malignancies in hairy cell leukemia.
    Jacobs RH; Vokes EE; Golomb HM
    Cancer; 1985 Sep; 56(6):1462-7. PubMed ID: 4027881
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Response to doxorubicin in hairy cell leukaemia.
    McCarthy D; Catovsky D
    Scand J Haematol; 1978 Nov; 21(5):445-7. PubMed ID: 734354
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Infectious complications in hairy cell leukemia.
    Kraut E
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():50-2. PubMed ID: 21504285
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review.
    Criscuolo M; Tosti ME; Broccoli A; Varettoni M; Maraglino AME; Anastasia A; Cantonetti M; Trentin L; Kovalchuk S; Orsucci L; Deodato M; Spolzino A; Volpetti S; Annibali O; Storti S; Stelitano C; Marchesi F; Morè S; Fianchi L; Falini B; Pulsoni A; Tiacci E; Zinzani PL; Pagano L
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672557
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epidemiology and environmental risk in hairy cell leukemia.
    Tadmor T; Polliack A
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):175-9. PubMed ID: 26614895
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Splenectomy and second malignancies in patients with Hodgkin lymphoma.
    Kooistra HA; Kluin-Nelemans HC; van Imhoff GW; van Dijk BA; de Bock GH; van der Kaaij MA
    Leuk Lymphoma; 2015 Jan; 56(1):230-1. PubMed ID: 24707939
    [No Abstract]   [Full Text] [Related]  

  • 67. Lethal skin cancers in hairy cell leukemia (two case reports).
    Toner GC; Holmes R; Kennedy JT; Schwarz MA
    Eur J Haematol; 1987 Jul; 39(1):82-5. PubMed ID: 3653376
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis.
    Epperla N; Zhao Q; Anghelina M; Neal J; Blachly JS; Rogers KA; Lozanski G; Oakes CC; Bhat SA; Zent CS; Banerji V; Grever M; Andritsos LA
    Am J Hematol; 2023 May; 98(5):E116-E118. PubMed ID: 36808760
    [No Abstract]   [Full Text] [Related]  

  • 69. The coexistence of second and third malignancies in adult-onset cancer patients.
    Giuliani J
    J Gastrointest Cancer; 2014 Sep; 45(3):395. PubMed ID: 24488436
    [No Abstract]   [Full Text] [Related]  

  • 70. Therapy-related second malignancies. Proceedings of a symposium. Boston, January 1992.
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-493. PubMed ID: 8468268
    [No Abstract]   [Full Text] [Related]  

  • 71. Is hairy-cell leukemia more common among farmers - a pilot-study.
    Rask-Andersen A; Hagberg H; Hardell L; Nordstrom M
    Oncol Rep; 1995 May; 2(3):447-50. PubMed ID: 21597756
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Second neoplasms in patients infected with HIV.
    Martín Asenjo M; Martín Guerra JM; Dueñas Gutiérrez CJ;
    Med Clin (Barc); 2019 Mar; 152(6):241-242. PubMed ID: 29843903
    [No Abstract]   [Full Text] [Related]  

  • 73. May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk?
    Francolini G; Ciccone LP; Di Cataldo V; Detti B; Simontacchi G; Loi M; Mangoni M; Desideri I; Meattini I; Livi L
    J Clin Oncol; 2021 Nov; 39(33):3762-3763. PubMed ID: 34534000
    [No Abstract]   [Full Text] [Related]  

  • 74. Is it really possible to cure hairy cell leukemia patients only with frontline therapy?
    Zinzani PL; Stefoni V; Broccoli A; Pellegrini C; Gandolfi L; Casadei B; Maglie R; Pileri S; Argnani L
    Ann Hematol; 2014 Sep; 93(9):1565-9. PubMed ID: 24752417
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hairy cell leukemia: clinicopathological and immunophenotypic study.
    Konkay K; Uppin MS; Uppin SG; Raghunadha Rao D; Geetha Ch; Paul TR
    Indian J Hematol Blood Transfus; 2014 Sep; 30(3):180-6. PubMed ID: 25114404
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hairy cell leukemia: a 'hair-raising' update.
    Topp ZZ; Saven A
    Expert Rev Hematol; 2014 Oct; 7(5):659-69. PubMed ID: 25148599
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hairy cell leukemia: Update on molecular profiling and therapeutic advances.
    Grever MR; Blachly JS; Andritsos LA
    Blood Rev; 2014 Sep; 28(5):197-203. PubMed ID: 25110197
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Unusual presentation of hairy cell leukemia: a case series of four clinically unsuspected cases.
    Venkatesan S; Purohit A; Aggarwal M; Manivannan P; Tyagi S; Mahapatra M; Pati HP; Saxena R
    Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):413-7. PubMed ID: 25332634
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?
    Freyer CW; Gupta N; Wetzler M; Wang ES
    Am J Hematol; 2015 Jan; 90(1):62-72. PubMed ID: 25284482
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Monnereau A; Slager SL; Hughes AM; Smith A; Glimelius B; Habermann TM; Berndt SI; Staines A; Norman AD; Cerhan JR; Sampson JN; Morton LM; Clavel J
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):115-24. PubMed ID: 25174032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.